21 julio 2015
In a phase 2 trial that included nearly 1,000 adults, the AS03 and MF59 adjuvants (a component that improves immune response of inactivated influenza vaccines) increased the immune responses to two doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted formulations inducing the highest amount of antibody response, according to a new study.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/SadfmMmmcd8″ height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/SadfmMmmcd8/150721111438.htm
